Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3077% below fair value
$3.16−0.23 (-6.78%)
Close on Nov 17, 2026Market cap $59.40MP/E –Yield –
Outset Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Outset Medical's operating income for the twelve months ending Jun 30, 2026 was -$66.04M. For fiscal 2025 it was -$66.71M. The highest annual figure on record is -$46.56M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$66.71M | – |
| FY2024 | Dec 31, 2024 | -$113.38M | – |
| FY2023 | Dec 31, 2023 | -$169.77M | – |
| FY2022 | Dec 31, 2022 | -$161.02M | – |
| FY2021 | Dec 31, 2021 | -$130.52M | – |
| FY2020 | Dec 31, 2020 | -$117.47M | – |
| FY2019 | Dec 31, 2019 | -$70.31M | – |
| FY2018 | Dec 31, 2018 | -$46.56M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.92M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.63M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.81M | – |
| Q2 FY2025 | Jun 30, 2025 | -$16.87M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$21.86M | – |
| Q3 FY2024 | Sep 30, 2024 | -$23.84M | – |
| Q2 FY2024 | Jun 30, 2024 | -$30.76M | – |
| Q1 FY2024 | Mar 31, 2024 | -$36.91M | – |
| Q4 FY2023 | Dec 31, 2023 | -$37.35M | – |
| Q3 FY2023 | Sep 30, 2023 | -$45.45M | – |
| Q2 FY2023 | Jun 30, 2023 | -$43.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$43.49M | – |
| Q4 FY2022 | Dec 31, 2022 | -$39.82M | – |
| Q3 FY2022 | Sep 30, 2022 | -$41.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$43.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$36.48M | – |
| Q4 FY2021 | Dec 31, 2021 | -$40.80M | – |
| Q3 FY2021 | Sep 30, 2021 | -$30.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$29.91M | – |
| Q1 FY2021 | Mar 31, 2021 | -$29.68M | – |
| Q4 FY2020 | Dec 31, 2020 | -$31.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$40.73M | – |
| Q2 FY2020 | Jun 30, 2020 | -$24.91M | – |
| Q1 FY2020 | Mar 31, 2020 | -$20.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -$18.57M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.45M | – |
See a number that looks wrong?